Skip to main content

Table 1 Baseline demographic data in chicken wing (CW) morphology patients compared with non-CW patients. All continuous variables are displayed as mean values ± standard deviation unless otherwise annotated

From: Left atrial appendage morphology and risk of stroke following pulmonary vein isolation for drug-refractory atrial fibrillation in low CHA2DS2Vasc risk patients

 

Total

CW

Non-CW

p-value

(n = 332)

(n = 190)

(n = 142)

Age

55 ± 13

54 ± 13

56 ± 13

0.263

Age ≥ 75 years

13 (15.2%)

5 (12.5%)

8 (5.6%)

0.490

Male gender

278 (83.7%)

160 (84.2%)

118 (83.1%)

0.785

HTN

200 (60.2%)

115 (60.5%)

85 (59.9%)

0.902

CHF

22 (6.6%)

14 (7.4%)

8 (5.6%)

0.518

DM2

48 (14.5%)

26 (13.7%)

22 (15.5%)

0.644

Vascular disease

140 (42.2%)

79 (41.6%)

61 (43.0%)

0.801

CHA2DS2Vasc > 1

162 (48.8%)

86 (45.3%)

76 (53.5%)

0.136

CHA2DS2Vasc, median (IQR)

1 (1, 3)

1 (1, 2)

2 (1, 4)

0.702

Prior CVA/TIA

16 (4.8%)

9 (4.7%)

7 (4.9%)

0.935

Post-PVI CVA

4 (1.2%)

4 (2.1%)

0 (0.0%)

0.034

Anticoagulation

 Warfarin

201 (69.6%)

123 (73.7%)

78 (63.9%)

0.055

 NOAC

88 (30.4%)

44 (26.3%)

44 (36.1%)

0.055

 Aspirin

43 (13.0%)

23 (12.1%)

20 (14.1%)

0.589

Pre-procedure INRa

2.2 ± 0.5

2.2 ± 0.5

2.2 ± 0.5

0.432

Rhythm prior to PVI

 Sinus rhythm

161 (48.8%)

88 (46.8%)

73 (51.4%)

0.407

 Atrial Arrhythmia

166 (50.3%)

97 (51.6%)

69 (48.6%)

0.589

 Paced

3 (0.9%)

3 (1.6%)

0 (0%)

0.131

Follow-up, mo., median (IQR)

72 (49, 97)

73 (49, 107)

69 (50, 92)

0.344

  1. CW chicken wing, HTN hypertension, CHF congestive heart failure, DM2 diabetes mellitus, type 2, CVA cerebral vascular accident/stroke, TIA transient ischemic attack, PVI pulmonary vein isolation, NOAC novel oral anticoagulant, INR international normalized ratio
  2. aOnly includes patients treated with warfarin at the time of pulmonary vein isolation (PVI)